Lori Goldstein
Medical Oncology · Philadelphia, PANPI 1598735219
Payments from drug & device makers
Across 114 payments — averaging $3546.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$279K
- Daiichi Sankyo Inc.$57K
- Mylan Inc.$15K
- Merck$10K
- AstraZeneca$8K
- Gilead$6K
- plus $29K from 9 others
What the payments were for
- Consulting fees$103,76881%
- Speaking & faculty fees$12,20810%
- Grants$3500%
- Travel & lodging$10,4218%
- Food & beverage$1,3921%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 31 | $278,660 |
| Daiichi Sankyo Inc. | 33 | $56,913 |
| Mylan Inc. | 11 | $15,288 |
| Merck | 8 | $10,329 |
| AstraZeneca | 4 | $7,910 |
| Gilead | 9 | $5,964 |
| Immunomedics, Inc. | 1 | $5,638 |
| Genentech USA, Inc. | 5 | $5,099 |
| Eisai CO., LTD. | 2 | $3,915 |
| GE HealthCare | 1 | $3,738 |
| Radius Health, Inc. | 2 | $3,650 |
| Amgen | 1 | $3,300 |
| Eisai Inc. | 2 | $2,000 |
| Dompe US, Inc. | 3 | $1,799 |
| Pfizer | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$404,253 in reported general payments places this provider in the 70th percentile of 238 medical oncology providers in Pennsylvania.
Other medical oncology in Philadelphia
- Sukhmani PaddaPhiladelphia$25.6M
- Peter O DwyerPhiladelphia$18M
- Margaret von MehrenPhiladelphia$17.4M
- Kim Reiss BinderPhiladelphia$16.9M
- Carl JunePhiladelphia$13M
- Takami SatoPhiladelphia$11.5M
- Vivek NarayanPhiladelphia$10.6M
- Ubaldo Martinez-OutschoornPhiladelphia$10.5M
- Neil PalmisianoPhiladelphia$10.1M
- Anthony OlszanskiPhiladelphia$9.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.